Economy · India
Mounjaro Becomes India's Top-Selling Drug Amid GLP-1 Injection Trend
Mounjaro has become India's highest-selling pharmaceutical drug, achieving sales of ₹1,256 crore in the 12 months ending August 2026. This represents a 502 percent increase in sales compared to the previous year. The surge in Mounjaro's sales is attributed to a broader trend of patients shifting towards GLP-1 (Glucagon-like peptide-1) injections for treatment.
How outlets across the spectrum covered it
L 0 C 2 R 0
- Centre (2): Business Today, The Hindu BusinessLine